| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200.3M | — | +63.5% |
| Cost of Revenue | $123.9M | — | +41.8% |
| Gross Profit | $76.5M | — | +117.0% |
| R&D Expense | $80.5M | — | +46.1% |
| SG&A Expense | $51.9M | — | +32.1% |
| Operating Income | -$56.0M | — | +5.4% |
| Pre-tax Income | -$46.8M | — | +23.8% |
| Income Tax | -$1.8M | — | -120.4% |
| Net Income | -$45.0M | — | +25.7% |
| EPS (Basic) | -$0.07 | — | +41.7% |
| EPS (Diluted) | -$0.07 | — | +41.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.21B | +45.5% | +297.7% |
| Short-term Investments | $177.9M | -5.4% | +42.0% |
| Accounts Receivable | $75.0M | +92.2% | +90.2% |
| Inventory | $183.1M | +15.6% | +45.8% |
| Current Assets | $1.80B | +31.8% | +148.4% |
| Total Assets | $2.82B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$50.3M | — | +7.2% |
| Capital Expenditures | $27.1M | — | -5.6% |
| Investing Cash Flow | -$35.7M | — | -24.9% |
| Financing Cash Flow | $463.3M | — | +301.1% |
| Free Cash Flow | -$77.4M | — | +6.6% |
| +124.7% |
| Current Liabilities | $402.3M | +20.3% | +15.6% |
| Long-term Debt | $36.9M | -75.8% | -89.3% |
| Total Liabilities | $555.6M | -7.8% | -32.5% |
| Stockholders' Equity | $2.26B | +31.5% | +425.0% |